• DTAB ratifies extension of timeline for revised Schedule M implementation for MSMEs

• Number of NSQ drugs has declined considerably in Gujarat during the last 10 years: Dr H G Koshia

• Indian pharma upholds Union govt’s blanket ban on trade with Pakistan in response to national security concerns

• DTAB recommends all antimicrobials to be considered as new drug under NDCT Rules